What’s the Best Way to Treat Chronic Tenosynovitis?
Question by ShakeRattleRollNY: What’s the best way to treat chronic tenosynovitis?
I obtained this condition above my left ankle about a couple of years ago playing soccer. It really hasn’t gone away; when I poke at that area, it feels like a fresh painful bruise. I’m able to run and move around since the injury is above where my sneaker tops off.
I heard that acupuncture is helpful. Your suggestions are welcome.
Thanks.
Best answer:
Answer by Sue O
i feel your pain! i had this when i played soccer my first year in college. i was also at a military school, so the combat boots we wore only made it worse. my injury did go away completely, but only after i spent about three weeks on crutches, giving the tendon TOTAL REST. it’s possible that since your case doesn’t sound as severe that accupuncture may help, but i really haven’t heard anything about that. do you take anti-inflammatories for it too? possible that advil and rest might do the trick…
Add your own answer in the comments!
What is Neurofeedback – Addictions and Substance Abuse – EEG Info Videos – Neurofeedback for Addictions and Substance Abuse. Discussion of research results showing a 77% effectiveness for neurofeedback. Interviews with professionals and clients using neurofeedback at addiction facilities.
Wendy Lecker: It's time to really put kids first
Filed under: drug abuse treatment outcome study
As reported in Education Week, researchers at the Center on the Developing Child at Harvard and elsewhere have studied how children's lives affect learning and development. They found that … Toxic stress includes physical or emotional abuse, chronic …
Read more on Stamford Advocate
New study supports 15-day fill program for oral cancer medications and again …
Filed under: drug abuse treatment outcome study
The study showed less than two-thirds of patients taking erlotinib, a once-daily oral tablet approved by the Food and Drug Administration (FDA) to treat non-small cell lung and pancreatic cancers, were adherent during the established 180-day follow-up …
Read more on Sacramento Bee
Novartis highlights key data in patients with hematologic diseases and breast …
Filed under: drug abuse treatment outcome study
CTL019 (CART-19) – Outcomes and extended follow-up from a Phase I/II study in patients with advanced, refractory and high-risk CLL and relapsed refractory ALL treated with CART-19 cells (ASH abstract #717; December 10, 5:00 PM EST). … The most common …
Read more on Reuters